Retatrutide: Designed to Last One of the newest GLP-1 medications in development is retatrutide , a triple agonist (GLP-1, GIP, and glucagon receptors) designed with an approximate 6-day half-life , thanks to advanced pharmaceutical engineering
Extend that over five years and the total exceeds $75,000
Start by drinking plenty of water throughout the day to stay hydrated, as dehydration can worsen nausea
The maintenance pill The ATTAIN-MAINTAIN trial involved participants from the companys earlier SURMOUNT-5 study, which directly compared semaglutide and tirzepatide
Gathering Recommendations: Insights from Friends and Professionals If you have doctors you like, youll want to check with their offices before switching insurance plans
Originally developed for the treatment of type 2 diabetes, these peptide-based drugs are now at the forefront of both metabolic disease management and obesity treatment, driving unprecedented market growth and industry attention